by Kohei Hasegawa, MD, MPH; Tuomas Jartti, MD; Yury A. Bochkov, PhD; James E. Gern, MD; Jonathan M. Mansbach, MD, MPH; Pedro A. Piedra, MD; Laura Toivonen, MD, PhD; and Carlos A. Camargo, Jr., MD, DrPH
To be published in The Pediatric Infectious Disease Journal, March 2019. doi: 10.1097/INF.0000000000002141
Bronchiolitis is an important public health problem in the United States and worldwide. In the United States, bronchiolitis is the leading cause of hospitalizations in infants, accounting for approximately 130,000 hospitalizations each year. In addition to the large acute disease burden, cohort studies have also demonstrated substantial chronic morbidity, with 30%–40% of children with severe bronchiolitis (bronchiolitis requiring hospitalization) developing childhood asthma.